STUDY OF WOUND HEALING ACTIVITY OF A MEDICINAL PRODUCT «GMDP LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INJECTION» PRODUCTION JSC «PEPTEK» (RUSSIA) IN THE SCHEMES OF COMBINED ANT...

by M. S. Zhuravleva, T. M. Andronova, E. I. Nesterova
Published 2019-01-01

Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication

by M R Konorev, T M Andronova, M E Matveenko
Published 2016-12-01

BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic

by O. V. Kalyuzhin, T. M. Andronova, A. V. Karaulov
Published 2020-12-01

The results of the study of the carcinogenic properties of glucosaminylmuramyldipeptide GMDP in chronic experiments in mice and rats

by Oleg S. Gudyrev, Tatyana M. Andronova, Evgeniya I. Nesterova
Published 2018-12-01

BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a...

by Oleg V. Kalyuzhin, Tatiana M. Andronova, Alexander V. Karaulov
Published 2021-01-01

CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE IN THE TREATMENT OF ATOPIC DISEASES

by N. V. Kolesnikova, I. G. Kozlov, S. V. Guryanova, E. A. Kokov, T. M. Andronova
Published 2016-04-01